Cargando…
MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1
In this study, we investigated the role of microRNA-363(miR-363) in ovarian cancer (OC) progression. MiR-363expression was downregulated in OC patient tissues and four OC cell lines (SKOV3, A2780, OVCAR and HO-8910). Low miR-363 levels were associated with advanced stage, lymph node metastasis, and...
Autores principales: | Lin, Yang, Xu, Tianmin, Zhou, Shunqing, Cui, Manhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731903/ https://www.ncbi.nlm.nih.gov/pubmed/29254193 http://dx.doi.org/10.18632/oncotarget.21417 |
Ejemplares similares
-
Retraction: MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1
por: Lin, Yang, et al.
Publicado: (2023) -
MicroRNA‐612 inhibits cervical cancer progression by targeting NOB1
por: Jin, Yang, et al.
Publicado: (2020) -
MicroRNA-363-3p downregulation in papillary thyroid cancer inhibits tumor progression by targeting NOB1
por: Dong, Su, et al.
Publicado: (2021) -
The circular RNA circ0005654 interacts with specificity protein 1 via microRNA-363 sequestration to promote gastric cancer progression
por: Yang, Cui, et al.
Publicado: (2021) -
MicroRNA-363-3p inhibits colorectal cancer progression by targeting interferon-induced transmembrane protein 1
por: Wang, Yun, et al.
Publicado: (2023)